Distinct chemotherapy‐associated anti‐cancer immunity by myeloid cells inhibition in murine pancreatic cancer models

Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy associated with an extremely poor prognosis. Chemotherapy, such as gemcitabine (GEM), is the only treatment for PDAC patients who are not suitable for radical surgical treatment; however, its anti‐tumor efficacy is limited. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Yoshio, Miyazawa, Masaki, Komura, Takuya, Yamada, Takeshi, Nasti, Alessandro, Yoshida, Keiko, Takabatake, Hisashi, Yamato, Masatoshi, Yamashita, Taro, Yamashita, Tatsuya, Mizukoshi, Eishiro, Okuzono, Mai, Ho, Tuyen Thuy Bich, Kawaguchi, Kazunori, Wada, Takashi, Honda, Masao, Kaneko, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398897/
https://www.ncbi.nlm.nih.gov/pubmed/30657234
http://dx.doi.org/10.1111/cas.13944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398897/
https://www.ncbi.nlm.nih.gov/pubmed/30657234
http://dx.doi.org/10.1111/cas.13944

Ejemplares similares